Andreas Boehle

1.5k total citations
15 papers, 1.1k citations indexed

About

Andreas Boehle is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Urology. According to data from OpenAlex, Andreas Boehle has authored 15 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Urology. Recurrent topics in Andreas Boehle's work include Bladder and Urothelial Cancer Treatments (11 papers), Urinary and Genital Oncology Studies (9 papers) and Urological Disorders and Treatments (3 papers). Andreas Boehle is often cited by papers focused on Bladder and Urothelial Cancer Treatments (11 papers), Urinary and Genital Oncology Studies (9 papers) and Urological Disorders and Treatments (3 papers). Andreas Boehle collaborates with scholars based in Germany, Spain and France. Andreas Boehle's co-authors include Richard Sylvester, Richard Zigeuner, Juan Palou, Morgan Rouprêt, Willem Oosterlinck, Michael A. O’Donnell, Marko Babjuk, Eero Kaasinen, Christine Chevreau and Leslie R. Laufman and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Chemistry and European Urology.

In The Last Decade

Andreas Boehle

15 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Boehle Germany 10 949 260 209 195 145 15 1.1k
Kees Hendricksen Netherlands 20 1.0k 1.1× 187 0.7× 194 0.9× 410 2.1× 162 1.1× 82 1.2k
J. SALVADOR-BAYARRI Spain 10 916 1.0× 166 0.6× 121 0.6× 308 1.6× 141 1.0× 16 997
Elisabeth E. Fransen van de Putte Netherlands 13 733 0.8× 211 0.8× 157 0.8× 234 1.2× 95 0.7× 28 835
Henry Rosevear United States 15 377 0.4× 97 0.4× 234 1.1× 139 0.7× 198 1.4× 26 717
Sławomir Poletajew Poland 15 408 0.4× 110 0.4× 198 0.9× 179 0.9× 154 1.1× 81 689
Jouko Viitanen Finland 13 283 0.3× 171 0.7× 249 1.2× 109 0.6× 111 0.8× 26 679
M. Babjuk Czechia 14 352 0.4× 90 0.3× 102 0.5× 106 0.5× 94 0.6× 28 478
Susan L. Groshen United States 10 286 0.3× 93 0.4× 65 0.3× 85 0.4× 90 0.6× 12 535
Takayuki Toyonaga Japan 9 389 0.4× 165 0.6× 105 0.5× 46 0.2× 60 0.4× 18 525
L Collste Sweden 17 318 0.3× 72 0.3× 187 0.9× 126 0.6× 124 0.9× 41 749

Countries citing papers authored by Andreas Boehle

Since Specialization
Citations

This map shows the geographic impact of Andreas Boehle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Boehle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Boehle more than expected).

Fields of papers citing papers by Andreas Boehle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Boehle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Boehle. The network helps show where Andreas Boehle may publish in the future.

Co-authorship network of co-authors of Andreas Boehle

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Boehle. A scholar is included among the top collaborators of Andreas Boehle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Boehle. Andreas Boehle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Matulay, Justin T., Mark S. Soloway, J. Alfred Witjes, et al.. (2020). Risk‐adapted management of low‐grade bladder tumours: recommendations from the International Bladder Cancer Group (IBCG). British Journal of Urology. 125(4). 497–505. 35 indexed citations
2.
3.
Boehle, Andreas, et al.. (2019). Comparison of outcome endpoints in intermediate- and high-risk prostate cancer after combined-modality radiotherapy. Brachytherapy. 19(1). 24–32. 3 indexed citations
4.
Kamat, Ashish M., Marc Colombel, Debasish Sundi, et al.. (2017). BCG-unresponsive non-muscle-invasive bladder cancer: recommendations from the IBCG. Nature Reviews Urology. 14(4). 244–255. 112 indexed citations
5.
6.
Rouprêt, Morgan, Richard Zigeuner, Juan Palou, et al.. (2012). Guía clínica para el diagnóstico y tratamiento de los carcinomas de las células uroteliales de las vías urinarias superiores: actualización de 2011. Actas Urológicas Españolas. 36(1). 2–14. 18 indexed citations
7.
Rouprêt, Morgan, Richard Zigeuner, Juan Palou, et al.. (2012). European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. Actas Urológicas Españolas (English Edition). 36(1). 2–14. 97 indexed citations
8.
Rouprêt, Morgan, Richard Zigeuner, Juan Palou, et al.. (2011). European Guidelines for the Diagnosis and Management of Upper Urinary Tract Urothelial Cell Carcinomas: 2011 Update. European Urology. 59(4). 584–594. 293 indexed citations
9.
O’Donnell, Michael A. & Andreas Boehle. (2006). Treatment options for BCG failures. World Journal of Urology. 24(5). 481–487. 76 indexed citations
10.
Meijden, Adrian P.M. van der, Richard Sylvester, Willem Oosterlinck, et al.. (2005). EAU Guidelines on the Diagnosis and Treatment of Urothelial Carcinoma in Situ. European Urology. 48(3). 363–371. 80 indexed citations
11.
Stoffregen, C., et al.. (2004). Immediate postoperative instillation of gemcitabine after transurethral resection of bladder tumors. Journal of Clinical Oncology. 22(14_suppl). 4685–4685. 2 indexed citations
12.
Stoffregen, C., et al.. (2004). Immediate postoperative instillation of gemcitabine after transurethral resection of bladder tumors. Journal of Clinical Oncology. 22(14_suppl). 4685–4685. 2 indexed citations
13.
Krüger, Stefan, et al.. (2004). Ki-67 Protein Concentrations in Urothelial Bladder Carcinomas Are Related to Ki-67-Specific RNA Concentrations in Urine. Clinical Chemistry. 50(8). 1461–1463. 10 indexed citations
14.
Kurdow, Roland, et al.. (2003). Implantation Metastasis of a Hypopharyngeal Carcinoma at the Site of a Percutaneous Endoscopic Gastrostomy. Endoscopy. 35(5). 462–462. 9 indexed citations
15.
Schuldes, H., et al.. (1985). Die Behandlung des Harnleitersteines mit der ESWL. Aktuelle Urologie. 16(6). 299–303. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kees Hendricksen Breakdown of academic impact, for papers by J. SALVADOR-BAYARRI Breakdown of academic impact, for papers by Elisabeth E. Fransen van de Putte Breakdown of academic impact, for papers by Henry Rosevear Breakdown of academic impact, for papers by Sławomir Poletajew Breakdown of academic impact, for papers by Jouko Viitanen Breakdown of academic impact, for papers by M. Babjuk Breakdown of academic impact, for papers by Susan L. Groshen Breakdown of academic impact, for papers by Takayuki Toyonaga Breakdown of academic impact, for papers by L Collste
Rankless by CCL
2026